251 related articles for article (PubMed ID: 2769951)
1. [Clinical evaluation of various tumor markers in pleural effusion and in the serum].
Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H
Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of five tumor marker assay in patients with lung cancer.
Mizushima Y; Tsuji H; Izumi S; Hirata H; Kin Y; Kawasaki A; Matsui S; Yano S
Anticancer Res; 1991; 11(1):91-5. PubMed ID: 2018388
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic significance of the tumor markers CEA, SCC and NSE in serum and bronchoalveolar lavage].
von Eiff M; Koch O; Appelhans N; Roos N; van de Loo J
Pneumologie; 1990 Feb; 44 Suppl 1():462-4. PubMed ID: 2164198
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of pleural effusion carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific-enolase in patients with lung cancer].
Fujii M; Kiura K; Kamei H; Segawa Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1988 May; 26(5):519-23. PubMed ID: 2852270
[No Abstract] [Full Text] [Related]
6. [A clinical study on CEA, TPA, ADA, ferritin, beta 2 microglobulin and sialic acid levels in pleural effusion].
Reshad K; Suzuki K; Itoi K; Takahashi Y; Hirata T; Yagi T; Sato A; Nakano Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Nov; 25(11):1174-80. PubMed ID: 3329690
[No Abstract] [Full Text] [Related]
7. [Diagnostic usefulness of neurospecific enolase determination in pleural fluid].
Romero S; Izquierdo M; Mauri M; Martín C; Almenar MV; García R; Padilla I
Med Clin (Barc); 1989 Nov; 93(15):568-71. PubMed ID: 2622261
[TBL] [Abstract][Full Text] [Related]
8. [Tumor marker in lung cancer].
Shijubo N; Abe S
Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790
[No Abstract] [Full Text] [Related]
9. [Diagnostic value of tissue polypeptide antigen in pleural effusions with malignant pleural mesothelioma].
Tokuyama T; Yoneda T; Hamada K; Yoshikawa M; Fu A; Tomoda K; Nakaya M; Narita N; Tamura M; Kitamura K
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jan; 33(1):39-43. PubMed ID: 7699966
[TBL] [Abstract][Full Text] [Related]
10. Carcinomatous and tuberculous pleural effusions. Comparison of tumor markers.
Niwa Y; Kishimoto H; Shimokata K
Chest; 1985 Mar; 87(3):351-5. PubMed ID: 3971760
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.
Niwa Y; Shimokata K
Jpn J Clin Oncol; 1986 Mar; 16(1):3-8. PubMed ID: 3009919
[TBL] [Abstract][Full Text] [Related]
12. Neuron-specific enolase in the diagnosis of small-cell lung cancer with pleural effusion: a negative report.
Pettersson T; Klockars M; Fröseth B
Eur Respir J; 1988 Aug; 1(8):698-700. PubMed ID: 2853080
[TBL] [Abstract][Full Text] [Related]
13. [The diagnostic value of carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) in pleural effusion].
Chen TM; Chang SC; Lu JY; Perng RP
Zhonghua Yi Xue Za Zhi (Taipei); 1987 Oct; 40(4):375-82. PubMed ID: 3502856
[No Abstract] [Full Text] [Related]
14. [Tumor markers. I. Their significance in the preoperative assessment of lung neoplasms].
Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R
Minerva Chir; 1990 Oct; 45(20):1265-72. PubMed ID: 1964495
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of pleural effusion--carcinoembryonic antigen (CEA) and adenosine deaminase (ADA) activities in pleural fluids].
Yagi S
Kekkaku; 1990 Dec; 65(12):775-83. PubMed ID: 2077254
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
[TBL] [Abstract][Full Text] [Related]
17. [Tumor markers. II. Their significance in the follow-up of patients after radical resection of lung neoplasms].
Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R
Minerva Chir; 1990 Oct; 45(20):1273-80. PubMed ID: 2082204
[TBL] [Abstract][Full Text] [Related]
18. [Immunological assay of the CA-125 value in pleural effusion in various types of pleuritis--its application as a differential diagnostic parameter of tuberculous or carcinomatous pleuritis].
Mitsutake Y; Hiromatsu Y; Saisho M; Tokunaga N; Ichikawa Y; Kaji M; Irie K
Gan No Rinsho; 1986 May; 32(5):453-7. PubMed ID: 3459902
[TBL] [Abstract][Full Text] [Related]
19. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
Toumbis M; Chondros K; Ferderigos AS; Daganou M; Dema A; Dalamaga A; Kakari S; Stringou E
Anticancer Res; 1992; 12(4):1267-70. PubMed ID: 1503419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
